文献速递糖尿病

1型糖尿病视网膜病变危险因素:DCCT/EDIC研究

Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study.
PubMed 文献 · Diabetes Care · 2019-03-04

基于DCCT/EDIC研究超过30年随访,评估1型糖尿病患者视网膜病变的可改变与非可改变危险因素。视网膜病变结局包括增殖性糖尿病视网膜病变、临床显著黄斑水肿和眼部手术。结果显示平均HbA1c是视网膜病变进展最强的危险因素,白蛋白排泄率升高和舒张压升高是其他可改变危险因素。

要点

  • 平均HbA1c是1型糖尿病视网膜病变进展最强的危险因素。
  • 白蛋白排泄率升高和舒张压升高是可改变的危险因素。
  • 病程延长和年龄增长也与视网膜病变风险增加相关。

核心结论

  • 平均HbA1c是视网膜病变进展最强的危险因素,白蛋白排泄率升高和舒张压升高是其他可改变危险因素。

研究设计与样本

  • DCCT/EDIC研究超过30年随访,采用Kaplan-Meier法估计无事件生存概率,Cox比例风险模型评估危险因素与视网膜病变风险的关联。

主要发现

  • 增殖性糖尿病视网膜病变、临床显著黄斑水肿和眼部手术的发生率分别为每1000人年12、14.5和7.6例。
  • 约65%、60%和70%的参与者分别未发生增殖性糖尿病视网膜病变、临床显著黄斑水肿和眼部手术。
  • 增殖性糖尿病视网膜病变危险因素按风险从高到低依次为平均HbA1c较高、1型糖尿病病程较长、白蛋白排泄率升高和平均舒张压较高。
  • 临床显著黄斑水肿危险因素按风险从高到低依次为平均HbA1c较高、1型糖尿病病程较长、年龄较大和舒张压较高。
  • 眼部手术危险因素按风险从高到低依次为平均HbA1c较高、年龄较大和1型糖尿病病程较长。

临床怎么用

  • 在1型糖尿病管理中,除血糖控制外,应关注白蛋白排泄率和舒张压以降低视网膜病变进展风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Diabetes Control and Complications Trial (DCCT) demonstrated that intensive therapy reduced the development and progression of retinopathy in type 1 diabetes (T1D) compared with conventional therapy. The Epidemiology of Diabetes Interventions and Complications (EDIC) study observational follow-up showed persistent benefits. In addition to glycemia, we now examine other potential retinopathy risk factors (modifiable and nonmodifiable) over more than 30 years of follow-up in DCCT/EDIC. RESEARCH DESIGN AND METHODS: The retinopathy outcomes were proliferative diabetic retinopathy (PDR), clinically significant macular edema (CSME), and ocular surgery. The survival (event-free) probability was estimated using the Kaplan-Meier method. Cox proportional hazards models assessed the association between risk factors and subsequent risk of retinopathy. Both forward- and backward-selection approaches determined the multivariable models. RESULTS: Rate of ocular events per 1,000 person-years was 12 for PDR, 14.5 for CSME, and 7.6 for ocular surgeries. Approximately 65%, 60%, and 70% of participants remained free of PDR, CSME, and ocular surgery, respectively. The greatest risk factors for PDR in descending order were higher mean HbA1c, longer duration of T1D, elevated albumin excretion rate (AER), and higher mean diastolic blood pressure (DBP). For CSME, risk factors, in descending order, were higher mean HbA1c, longer duration of T1D, and greater age and DBP and, for ocular surgeries, were higher mean HbA1c, older age, and longer duration of T1D. CONCLUSIONS: Mean HbA1c was the strongest risk factor for the progression of retinopathy. Although glycemic control is important, elevated AER and DBP were other modifiable risk factors associated with the progression of retinopathy.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Hainsworth DP, Bebu I, Aiello LP, et al. Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes Care. 2019. PMID: 30833368. doi:10.2337/dc18-2308

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。